Stay updated on ALT-801 in Overweight and Obese T2DM: Clinical Trial
Sign up to get notified when there's something new on the ALT-801 in Overweight and Obese T2DM: Clinical Trial page.

Latest updates to the ALT-801 in Overweight and Obese T2DM: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocation information was updated: new site locations were added and existing site listings removed, the page revision was updated to v3.3.3, and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.7%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe funding-status notice at the bottom of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedThe new screenshot appears to reflect non-substantive UI adjustments to the Study Details page without altering core trial information (eligibility, arms, outcomes, or timelines). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check91 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference5%

- Check98 days agoChange DetectedPage now indicates Revision: v3.1.0 and removes several drug-safety related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, implying content consolidation with a version upgrade.SummaryDifference0.6%

Stay in the know with updates to ALT-801 in Overweight and Obese T2DM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-801 in Overweight and Obese T2DM: Clinical Trial page.